The Recruitment of Systemic-to-Pulmonary Arterial Collaterals in Chronic and Severe Precapillary Pulmonary Hypertension as an Adaptive or Misguided Mechanism
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The clinical impact of systemic-to-pulmonary arterial collaterals (SPCs) across pulmonary hypertension (PH) groups remains unclear. The authors evaluated the prevalence, clinical correlates, and prognostic relevance of SPCs in a comprehensive PH cohort. METHODS: The authors retrospectively analyzed 434 adult PH patients diagnosed per European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines. Baseline risk was evaluated using multiparametric risk scores. All patients underwent diagnostic heart catheterization and angiography, with SPC recruitment semi-quantitatively graded from 0 (none) to 3 (severe, high grade: 2-3). RESULTS: Mean age was 51.9 ± 18.2 years (61.1% female; groups 1, 2, 3, and 4 comprised 51.6%, 3.4%, 10.1%, and 33.2%, respectively). High-grade SPCs were significantly more prevalent in group 4 (58.3%) compared to groups 1 (30.4%), 2 (20.0%), and 3 (6.8%) (P <.001). Higher SPC grade significantly correlated with PH severity across clinical, echocardiographic, hemodynamic, and risk score measures (P <.001). Although higher SPC grades were linked to clinical worsening requiring parenteral prostacyclins (P = .027), they were not associated with overall 5-year survival, regardless of pulmonary vascular resistance severity or non-CTEPH etiology (P = .920). Only the Registry to Evaluate Early and Long-Term PAH Disease Management 2.0 score independently predicted mortality (hazard ratio [HR] = 1.19, P <.001, 95% CI: 1.13-1.26). CONCLUSION: Systemic-to-pulmonary arterial collaterals are recruited across all PH etiology groups beyond group 4. While SPC recruitment serves as a marker of advanced pulmonary vascular involvement and elevated risk status, it does not act as an independent driver of long-term mortality.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7235019011
